OPTICALLY-ACTIVE DIHYDROZEATINS
R-(+)-DIHYDROZEATIN (R-DZ) [(+)-6-(R)-(4-hydroxy-3-methylbutylamino)purine]
| MW 221.26; crystalline; purity > 98% (HPLC) |
|
CAS: 37789-32-5; C10H15N5O |
| 028
0601 |
1 |
mg |
| 028
0602 |
2 |
mg |
| 028
0603 |
2 |
mg |
S-(-)-DIHYDROZEATIN (S-DZ) [(-)-6-(S)-(4-hydroxy-3-methylbutylamino)purine]
| MW 221.26; crystalline; purity > 98% (HPLC) |
|
CAS: 14742-97-3; C10H15N5O |
| 029
0601 |
1 |
mg |
| 029
0602 |
2 |
mg |
| 029
0603 |
5 |
mg |
R-(-)-DIHYDROZEATIN RIBOSIDE (R-DZR)
[(-)-6-(R)-4-hydroxy-3-methylbutylamino-9-β-D-ribofuranosylpurine]
| MW 353.38; crystalline; purity > 97% (HPLC) |
|
CAS: 64070-21-9; C15H23N5O5 |
| 028
0611 |
1 |
mg |
| 028
0612 |
2 |
mg |
| 028
0613 |
5 |
mg |
S-(-)-DIHYDROZEATIN RIBOSIDE (S-DZR)
[(-)-6-(S)-4-hydroxy-3-methylbutylamino-9-β-D-ribofuranosylpurine]
| MW 353.38; crystalline; purity > 97% (HPLC) |
|
CAS: 64070-22-0; C15H23N5O5 |
| 029
0611 |
1 |
mg |
| 029
0612 |
2 |
mg |
| 029
0613 |
5 |
mg |
R-(-)-DIHYDROZEATIN
RIBOSIDE-5'-MONOPHOSPHATE SODIUM SALT (R-DZMP) [(-)-6-(R)-(4-hydroxy-3-methylbutylamino)-9-β-D-ribofuranosylpurine-5'-monophosphate disodium monohydrate]
| MW 497.35;
crystalline; purity > 95% (HPLC) |
|
CAS: NONE; C15H22N5Na2O8P.H2O |
| 028
5011 |
1 |
mg |
| 028
5012 |
2 |
mg |
| 028
5013 |
5 |
mg |